Investigation of Circulating MicroRNA Levels in Antibody-Mediated Rejection After Kidney Transplantation

被引:1
|
作者
Nagy, Peter Ferenc [1 ]
Pocsi, Marianna [2 ]
Fejes, Zsolt [2 ]
Bidiga, Laszlo [3 ]
Szabo, Eszter [1 ]
Balogh, Orsolya [1 ]
Szollosi, Gergo Jozsef [4 ]
Nagy, Bela, Jr. [2 ]
Nemes, Balazs [1 ]
机构
[1] Univ Debrecen, Fac Med, Inst Surg, Dept Organ Transplantat, Debrecen, Hungary
[2] Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary
[3] Univ Debrecen, Fac Med, Dept Pathol, Debrecen, Hungary
[4] Univ Debrecen, Fac Publ Hlth, Dept Intervent Epidemiol, Debrecen, Hungary
关键词
EXPRESSION;
D O I
10.1016/j.transproceed.2022.10.044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. One of the most important possible complications determining long-term graft survival after kidney transplant is antibody-mediated rejection (ABMR). The criterion standard approach to recognize ABMR is currently the kidney biopsy with histopathologic analysis. However, this test has limitations because of difficulties in timing of sampling, the evaluability of histology because of the questionable representativeness of specimens, and the limited number of this intervention. Hence, new reliable, noninvasive biomarkers are required to detect the development of ABMR in time. Methods. In this study, we analyzed the clinical data of 45 kidney transplant patients (mean age of 44.51 years, 20 male and 25 female subjects). These participants were recruited into 5 subcohorts based on their clinical status, histologic findings, and level of donor-specific anti-HLA antibodies. Circulating microRNAs (miR-21, miR-181b, miR-146a, miR-223, miR-155, miR-150) in plasma samples were quantified by quantitative polymerase chain reaction and their levels were correlated with the clinical characteristics in different subgroups. Results. The relative expression of plasma miR-155 (P = .0003), miR-223 (P = .0316), and miR-21 (P = .0147) were significantly higher in patients who had subsequent histology-approved ABMR with donor-specific anti-HLA antibody positivity (n = 10) than in the "triple negative" group (n = 21), and miR-155 showed the highest sensitivity (90%) and specificity (81%) to indi-cate ABMR development based on receiver operating characteristic analysis. Conclusions. According to our preliminary data, plasma miR-155, miR-21, and miR-223 can indicate the development of ABMR after kidney transplant in correlation with classic clinical parameters. However, future studies with larger number of participants are necessary to further evaluate the diagnostic properties of blood miRNAs in prediction of this life-threatening condition.
引用
收藏
页码:2570 / 2577
页数:8
相关论文
共 50 条
  • [41] Circulating microRNA Biomarkers in Cellular and Antibody-Mediated Heart Transplant Rejection
    Shah, P.
    Agbor-Enoh, S.
    Bagchi, P.
    defilippi, C. R.
    Mercado, A.
    Diao, G.
    Morales, D. J.
    Shah, K. B.
    Najjar, S. S.
    Feller, E.
    Hsu, S.
    Rodrigo, M. E.
    Lewsey, S. C.
    Jang, M. K.
    Marboe, C.
    Berry, G. J.
    Khush, K. K.
    Valantine, H. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S93 - S93
  • [42] Elevated Circulating IL-10 Producing Breg, but Not Regulatory B Cell Levels, Restrain Antibody-Mediated Rejection After Kidney Transplantation
    Luo, Yongsheng
    Luo, Feifei
    Zhang, Kuanxin
    Wang, Shilei
    Zhang, Haojie
    Yang, Xianlei
    Shang, Wenjun
    Wang, Junxiang
    Wang, Zhigang
    Pang, Xinlu
    Feng, Yonghua
    Liu, Lei
    Xie, Hongchang
    Feng, Guiwen
    Li, Jinfeng
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [43] Acute antibody-mediated rejection after intestinal transplantation
    Guo-Sheng Wu
    Ruy J Cruz Jr
    Jun-Chao Cai
    World Journal of Transplantation, 2016, 6 (04) : 719 - 728
  • [44] Acute antibody-mediated rejection after pancreas transplantation
    Rangel, Erika Bevilaqua
    Costa Malheiros, Denise Maria Avancini
    Antunes, Irina
    Torres, Margareth
    Ribeiro Castro, Maria Cristina
    Crescentini, Fabio
    Genzini, Tercio
    de Miranda, Marcelo Perosa
    EINSTEIN-SAO PAULO, 2008, 6 (03): : 311 - 322
  • [45] Alemtuzumab Induction and Antibody-Mediated Kidney Rejection After Simultaneous Pancreas-Kidney Transplantation
    Pascual, Julio
    Pirsch, John D.
    Odorico, Jon S.
    Torrealba, Jose R.
    Djamali, Arjang
    Becker, Yolanda T.
    Voss, Barbara
    Leverson, Glen E.
    Knechtle, Stuart J.
    Sollinger, Hans W.
    Samaniego-Picota, Milagros D.
    TRANSPLANTATION, 2009, 87 (01) : 125 - 132
  • [46] Treatment of antibody-mediated rejection after liver transplantation
    Tan, E.
    Gomez-Aldana, A.
    Fuad, M.
    Fischer, S.
    Kiernan, J.
    Kai, D.
    Doddington, D.
    Bhat, M.
    Lilly, L.
    Tsien, C.
    Selzner-Malekkiani, N.
    Shwaartz, C.
    Sapisochin, G.
    Sayed, B.
    Ghanekar, A.
    Reichman, T.
    Cattral, M.
    McGilvray, I.
    Selzner, M.
    Jaeckel, E.
    LIVER TRANSPLANTATION, 2024, 30 : 149 - 149
  • [47] Acute antibody-mediated rejection after lung transplantation
    Witt, Chad A.
    Gaut, Joseph P.
    Yusen, Roger D.
    Byers, Derek E.
    Iuppa, Jennifer A.
    Bain, K. Bennett
    Patterson, G. Alexander
    Mohanakumar, Thalachallour
    Trulock, Elbert P.
    Hachem, Ramsey R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (10): : 1034 - 1040
  • [48] OUTCOME OF ANTIBODY-MEDIATED REJECTION AFTER LIVER TRANSPLANTATION
    Staufer, Katharina
    Herac, Merima
    Munda, Petra
    Boehmig, Georg
    Soliman, Thomas
    Fischer, Gottfried
    Trauner, Michael
    TRANSPLANT INTERNATIONAL, 2017, 30 : 456 - 456
  • [49] Acute Antibody-mediated Rejection After Lung Transplantation
    Morrell, Matthew R.
    Patterson, G. Alexander
    Trulock, Elbert P.
    Hachem, Ramsey R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (01): : 96 - 100
  • [50] Acute and chronic antibody-mediated rejection in pediatric kidney transplantation
    Pape, Lars
    Becker, Jan U.
    Immenschuh, Stephan
    Ahlenstiel, Thurid
    PEDIATRIC NEPHROLOGY, 2015, 30 (03) : 417 - 424